)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Insulet
Insulet (PODD) investor relations material
Insulet Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary6 Jul, 2026
Strategic vision and mission
Aims to reduce the daily burden of diabetes globally through empathetic, science-driven innovation.
Focuses on transforming lives by integrating advanced technology and user-centric design.
Market leadership and growth
Holds the top position in automated insulin delivery (AID) systems in the U.S. and Europe, with over 600,000 active customers and presence in 26 global markets.
Drove 66% of global AID market growth from 2020 to 2025, achieving nearly 50% global revenue share.
Achieved $2.7B in 2025 revenue, with a 25% CAGR in total revenue and 55% CAGR in adjusted EPS from 2021 to 2025.
Innovation and product pipeline
Omnipod 5 ecosystem enhancements include improved algorithms, full CGM integration, and streamlined onboarding.
Omnipod 6, launching in 2027, will offer fully closed-loop AID for T2D, seamless connectivity, and a new digital experience.
Future platforms aim for further automation and ease of use, with significant R&D investment planned.
Outline the expansion plan for Asian markets
Explain the T2D fully closed-loop roadmap
Impact of new facilities on margin expansion
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Insulet
- Innovation and clinical performance drive robust growth and margin expansion in diabetes care.PODD
Bank of America Global Healthcare Conference 202610 Jul 2026 - Q3 2024 revenue up 25.7% to $543.9M; guidance raised on Omnipod 5 and FDA expansion.PODDQ3 20249 Jul 2026
- Q2 revenue up 23%, net income surged, and full-year guidance raised on Omnipod 5 growth.PODDQ2 20249 Jul 2026
- Q1 2025 revenue up 30% to $569M, gross margin 71.9%, 2025 guidance raised on Omnipod 5 growth.PODDQ1 20258 Jul 2026
- Innovation, global expansion, and strong growth drive leadership in diabetes management.PODD46th Annual William Blair Growth Stock Conference3 Jun 2026
- Strong growth, innovation, and all proposals approved amid focus on long-term value.PODDAGM 202620 May 2026
- Q1 2026 revenue up 33.9% to $761.7M, net income $91.1M, and FY guidance raised.PODDQ1 20266 May 2026
- Market leader in AID, driving growth with innovation, global reach, and strong financials.PODDInvestor presentation6 May 2026
- Omnipod 5 delivers robust, individualized glycemic control and cost savings in diabetes care.PODDOmnipod® 5 competitive clinical performance presentation5 May 2026
Next Insulet earnings date
Q2 20265 Aug, 2026
Insulet
Next Insulet earnings date
Q2 20265 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage